Financhill
Back

Biogen Vs. Bristol-Myers Squibb Industry Stock Comparison

Sell
45

BIIB
Biogen

Last Price:
230.59
Seasonality Move:
6.74%
Sell
35

BMY
Bristol-Myers Squibb

Last Price:
44.01
Seasonality Move:
-0.39%
Sell
45
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $230.57. The Score for BIIB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy, Sell or Hold?

  • The current Bristol-Myers Squibb [BMY] share price is $44.03. The Score for BMY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $230.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMY Stock Price Chart

What is Bristol-Myers Squibb's stock price today?

  • The Bristol-Myers Squibb share price today is $44.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing slight buying pressure.

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.03 Buy
Relative Strength Index (14 RSI): 66.22 Buy
Chaikin Money Flow: 867694 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (198.37 - 225.63) Buy
Bollinger Bands (100): (207.58 - 246.04) Buy

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.27 Sell
Relative Strength Index (14 RSI): 32.78 Sell
Chaikin Money Flow: 811113 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.66 - 47.74) Sell
Bollinger Bands (100): (46.83 - 52.49) Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 226.53 Buy
20-day SMA: 216.55 Buy
50-day SMA: 213.1 Buy
200-day SMA: 239.51 Sell
8-day EMA: 226.83 Buy
20-day EMA: 219.6 Buy
50-day EMA: 217.31 Buy
200-day EMA: 236.4 Sell

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.48 Sell
20-day SMA: 45.04 Sell
50-day SMA: 48.89 Sell
200-day SMA: 52.74 Sell
8-day EMA: 44.42 Sell
20-day EMA: 45.36 Sell
50-day EMA: 47.54 Sell
200-day EMA: 53 Sell

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $1.74 per share.

Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.21 per share, a decrease this year of $6.83 per share, and an increase next year of $6.39 per share.

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bristol-Myers Squibb Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):